16 results on '"Piault, E"'
Search Results
2. PCN224 - Understanding Patients’ Ability to Function in Order to Inform Clinical Benefit in Oncology Studies
3. Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis: The Role of the Patient-Reported Outcome Consortium’s RA Working Group
4. PND24 EVALUATING THE IMPACT OF RESTLESS LEGS SYNDROME (RLS) ON NEXT DAY FUNCTIONING
5. PSY41 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PAIN TREATMENT: OVERVIEW OF US AND EUROPEAN DRUG APPROVALS
6. PCN88 LEVERAGING PATIENT-REPORTED OUTCOMES TO DEFINE FATIGUE IN CANCER
7. PMC48 UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA
8. PHP82 RECENT TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA
9. PND39 PATIENT-REPORTED OUTCOME (PRO) LABELING CLAIMS IN PARKINSON'S DISEASE: OVERVIEW OF US AND EUROPEAN DRUG APPROVALS
10. PCN57 PATIENT REPORTED OUTCOMES IN LABELING FOR ONCOLOGY PRODUCTS: REVIEW OF FDA AND EMEA LABELS
11. PUK26 LINGUISTIC VALIDATION OF THE OVERACTIVE BLADDER SATISFACTION QUESTIONNAIRE (OAB-S) IN 13 LANGUAGES
12. PUK22 COMPARISON OF THE PRO ENDPOINTS FOUND IN LABELING CLAIMES OF URINARY INCONTINENCE DRUGS WITH THOSE RECOMMENDED BY THE CORRESPONDING EMEA NOTE FOR GUIDANCE
13. PMC18 THE PROLABELS DATABASE: A NEW ON-LINE TOOL TO EXPLORE THE WORDING AND TYPES OF PRO INCLUDED IN APPROVED MEDICINAL PRODUCTS LABELS
14. PUK13 GENERIC VS. DISEASE-SPECIFIC SATISFACTION MEASURES: SELECTING A SATISFACTION MEASURE FOR OVERACTIVE BLADDER STUDIES
15. PMD5: IMPROVING REPORTS OF PRO DATA TO SUPPORT AN EFFECTIVENESS CLAIM
16. PMS82 Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis: The Role of the Patient-Reported Outcome Consortium’s RA Working Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.